Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,884 | 752 | 90.6% |
| Consulting Fee | $1,200 | 1 | 8.4% |
| Education | $141.69 | 8 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,840 | 91 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,631 | 64 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $1,370 | 6 | $0 (2021) |
| ABBVIE INC. | $939.02 | 58 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $835.99 | 44 | $0 (2021) |
| Lilly USA, LLC | $755.92 | 66 | $0 (2021) |
| GlaxoSmithKline, LLC. | $731.80 | 34 | $0 (2021) |
| PFIZER INC. | $689.04 | 54 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $542.40 | 44 | $0 (2021) |
| Amarin Pharma Inc. | $475.21 | 23 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.18 | 1 | Novo Nordisk Inc ($121.18) |
| 2023 | $16.36 | 1 | PFIZER INC. ($16.36) |
| 2022 | $277.24 | 5 | ABBVIE INC. ($142.88) |
| 2021 | $4,025 | 157 | Biohaven Pharmaceuticals, Inc. ($1,370) |
| 2020 | $2,490 | 138 | AstraZeneca Pharmaceuticals LP ($435.92) |
| 2019 | $2,491 | 156 | Novo Nordisk Inc ($581.19) |
| 2018 | $2,074 | 139 | AstraZeneca Pharmaceuticals LP ($283.75) |
| 2017 | $2,729 | 164 | AstraZeneca Pharmaceuticals LP ($586.48) |
All Payment Transactions
761 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $121.18 | General |
| Category: Obesity | ||||||
| 11/22/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: VACCINES | ||||||
| 06/29/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes Care | ||||||
| 05/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: NEUROSCIENCE | ||||||
| 04/14/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $117.28 | General |
| Category: Diabetes | ||||||
| 03/25/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $122.87 | General |
| Category: NEUROSCIENCE | ||||||
| 12/28/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/21/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: DIABETES | ||||||
| 12/17/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.56 | General |
| Category: DIABETES | ||||||
| 12/09/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Diabetes | ||||||
| 12/02/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: VACCINES | ||||||
| 12/02/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Diabetes | ||||||
| 11/22/2021 | Abbott Laboratories | FreeStyle Libre 2 (Device) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Diabetes Care | ||||||
| 11/22/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $7.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: DIABETES | ||||||
| 11/18/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: Neuroscience | ||||||
| 11/18/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 6 | 160 | 172 | $12,589 | $5,698 |
| 2021 | 11 | 504 | 631 | $46,793 | $25,788 |
| 2020 | 9 | 390 | 515 | $37,448 | $16,863 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 45 | $6,570 | $2,525 | 38.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 18 | 18 | $3,150 | $2,230 | 70.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 22 | $2,178 | $675.93 | 31.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 52 | 54 | $432.00 | $161.22 | 37.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 21 | 21 | $151.00 | $72.84 | 48.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 12 | 12 | $108.00 | $33.40 | 30.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 133 | $19,418 | $9,320 | 48.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 47 | 47 | $6,925 | $5,875 | 84.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 79 | $7,821 | $4,193 | 53.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 36 | 36 | $2,340 | $2,336 | 99.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 16 | $3,136 | $1,632 | 52.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 34 | 35 | $2,100 | $846.00 | 40.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 42 | 42 | $2,082 | $664.90 | 31.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 103 | 139 | $1,224 | $407.09 | 33.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 15 | 15 | $750.00 | $237.49 | 31.7% |
| 81002 | Urinalysis, manual test | Office | 2021 | 52 | 61 | $549.00 | $212.28 | 38.7% |
| 81003 | Automated urinalysis test | Office | 2021 | 26 | 28 | $448.00 | $63.00 | 14.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 86 | 140 | $20,440 | $7,874 | 38.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 33 | 33 | $4,125 | $3,676 | 89.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 46 | 68 | $6,732 | $2,689 | 39.9% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 16 | 16 | $1,034 | $963.50 | 93.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 20 | 22 | $1,320 | $460.52 | 34.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 26 | 26 | $832.00 | $411.98 | 49.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 103 | 137 | $2,055 | $402.88 | 19.6% |
| 81002 | Urinalysis, manual test | Office | 2020 | 49 | 62 | $558.00 | $211.90 | 38.0% |
About Dr. Robert Potter, MD
Dr. Robert Potter, MD is a Internal Medicine healthcare provider based in Noblesville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346334562.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Potter, MD has received a total of $14,225 in payments from pharmaceutical and medical device companies, with $121.18 received in 2024. These payments were reported across 761 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($12,884).
As a Medicare-enrolled provider, Potter has provided services to 1,054 Medicare beneficiaries, totaling 1,318 services with total Medicare billing of $48,349. Data is available for 3 years (2020–2022), covering 26 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties General Practice, Family Medicine
- Location Noblesville, IN
- Active Since 10/03/2006
- Last Updated 09/19/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1346334562
Products in Payments
- NURTEC ODT (Drug) $1,370
- Ozempic (Drug) $1,004
- JARDIANCE (Drug) $830.07
- VRAYLAR (Drug) $815.49
- FARXIGA (Drug) $547.08
- Vascepa (Drug) $475.21
- TRULICITY (Drug) $386.72
- TRELEGY ELLIPTA (Drug) $326.22
- XARELTO (Drug) $323.10
- JANUVIA (Drug) $312.76
- SYMBICORT (Drug) $297.16
- BEVESPI AEROSPHERE (Drug) $276.82
- BYDUREON (Drug) $270.51
- Horizant (Drug) $260.78
- CHANTIX (Drug) $240.27
- UBRELVY (Drug) $233.13
- Livalo (Drug) $202.37
- Saxenda (Drug) $201.04
- BREZTRI AEROSPHERE (Drug) $192.59
- HMG-CoA reductase inhibitor. (Drug) $190.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Noblesville
Dr. Navneet Lather, Md, Mph, MD, MPH
Internal Medicine — Payments: $105,289
John Tuttle, Md, MD
Internal Medicine — Payments: $28,966
Dr. Ahmad Saltagi, Md, MD
Internal Medicine — Payments: $19,269
Derek Murphy, Md, MD
Internal Medicine — Payments: $10,323
David Tetrick
Internal Medicine — Payments: $6,632
Christian Verhagen, M.d, M.D
Internal Medicine — Payments: $4,449